CollabRx, Inc. Message Board

They backed CLRX into this shell and preserved much of the tax loss which is huge going forward.

UP UP UP

Go listen to last conference call. decide for yourself. Deal flow on the rise

Look at the chart since 2000.
Was $500 per share "split adjusted"....lost 99% of value since 2000.
Founded in 1972....where has 40 years gotten investors?

genetic testing companies need this tech and we are ahead of mkt, big game changer as the deals starting to come in at a quicker pace. Genetic testing space is going to explode as costs come down and need way to consolidate all the data. we are first to market. good luck everyone

Do some dd on her..

Perfect news and perfect setup to run huge today.

Sentiment: Strong Buy

One founder shareholder is Bio.be, a company owned by the Institute of Pathology and Genetics (IPG), the Belgian leader in genetic and pathological analyses, with a patient group coming from half the francophone hospitals in the country.

Deal flow is increasing. Company delivering on what it said in conference call. If you have not listened please do, doing what they said they would. This latest deal gets a foothold in europe.

CLRX should do well the news this A.M. was very good for them.... When the fun here is over please do not forget RCON has a pending explosive earnings report due out.

$5 million cash on Balance Sheet; $6 million market capitalization, $0 Debt = $ 1 million of Enterprise Value

Need stock to be in better institutional hands = need one-on-one road shows to take place
Need a small capital raise with a healthcare fund = spending $1 million of cash per quarter - dilution is okay but only with the right partner!
Need more depth in management team = two deal people, one of which is Mika, and the other, has a big academic background. They've surprisingly done a pretty good job signing deals in the past year, but imagine the deals they could sign with a seasoned healthcare deal veteran (i.e. need a COO). FYI, Thomas Mika making $250+ in compensation = 25% of Enterprise Value
Need a CMO - someone to get the word out to physicians, healthcare service providers and patients

CLRX has a HUGE data opportunity, has signed some attractive partners (especially LIFE), is developing a major oncology network / editorial boards both vertically (cancer common) and horizontally (cancer specific)...all of which could make CLRX's knowledge database and services a key value driver with actionable intelligence at the point of care. Genetic testing is exploding...to figure out what to do as a healthcare service provider / physician will become increasingly complex and patient specific. Knowledge of which test to prescribe, which trial to enter, and which drug to take, all of which will be patient-specific based on their own DNA / Genome, is the future of medicine. It is ramping up quickly. CLRX has the opportunity to be a primary data provider to help this future happen. It's network alone is worth multiples of current valuation.

Adding to my position.

Space is heating. Patience

CRM cloud king.
Just another tidbit. Continue adding deals, partnerships and someone is going to come knocking. Net of cash dirt cheap chance to get into hot sector. diagnostic cloud play. Just a matter of time imo

the same author been on fire- cbmx and today he did cali- got good track record

http://seekingalpha.com/article/924081-collabrx-the-future-salesforce-of-the-health-care-industry